Stéphane Bancel, CEO of Moderna

Mod­er­na starts up third HIV vac­cine tri­al, part­ner­ing with IAVI to study its shot in Africa

Ear­li­er this year, Mod­er­na and non­prof­it re­search group IAVI (In­ter­na­tion­al AIDS Vac­cine Ini­tia­tive) an­nounced that the first dos­es of an mR­NA an­ti-HIV vac­cine can­di­date had …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.